Xact Kapitalforvaltning AB raised its stake in Stericycle, Inc. (NASDAQ:SRCL) by 27.7% during the second quarter, Holdings Channel reports. The institutional investor owned 17,041 shares of the business services provider’s stock after buying an additional 3,700 shares during the period. Xact Kapitalforvaltning AB’s holdings in Stericycle were worth $1,301,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Stericycle by 3.2% in the first quarter. Vanguard Group Inc. now owns 8,094,210 shares of the business services provider’s stock valued at $670,929,000 after buying an additional 251,061 shares in the last quarter. BlackRock Inc. boosted its stake in Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock valued at $421,877,000 after buying an additional 4,947,900 shares in the last quarter. State Street Corp boosted its stake in Stericycle by 1.1% in the first quarter. State Street Corp now owns 3,470,873 shares of the business services provider’s stock valued at $287,693,000 after buying an additional 39,382 shares in the last quarter. FMR LLC boosted its stake in Stericycle by 8.2% in the first quarter. FMR LLC now owns 2,925,407 shares of the business services provider’s stock valued at $242,486,000 after buying an additional 221,262 shares in the last quarter. Finally, Fairpointe Capital LLC boosted its stake in Stericycle by 14.5% in the first quarter. Fairpointe Capital LLC now owns 2,391,424 shares of the business services provider’s stock valued at $198,225,000 after buying an additional 302,369 shares in the last quarter. Hedge funds and other institutional investors own 95.50% of the company’s stock.

Shares of Stericycle, Inc. (NASDAQ:SRCL) opened at 76.30 on Monday. Stericycle, Inc. has a 52 week low of $71.52 and a 52 week high of $107.74. The company has a market capitalization of $6.51 billion, a price-to-earnings ratio of 39.76 and a beta of 0.14. The company’s 50 day moving average price is $80.67 and its 200-day moving average price is $80.83.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, May 4th. The business services provider reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. The company had revenue of $892.40 million during the quarter, compared to analyst estimates of $874.34 million. Stericycle had a return on equity of 14.40% and a net margin of 5.23%. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.11 earnings per share. Analysts anticipate that Stericycle, Inc. will post $4.62 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/xact-kapitalforvaltning-ab-boosts-position-in-stericycle-inc-srcl/1444626.html.

SRCL has been the subject of several research analyst reports. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a research report on Wednesday, July 5th. Barclays PLC initiated coverage on Stericycle in a research report on Thursday, April 13th. They set an “overweight” rating and a $100.00 target price for the company. Jefferies Group LLC reiterated a “buy” rating and set a $108.00 target price on shares of Stericycle in a research report on Thursday. BMO Capital Markets initiated coverage on Stericycle in a research report on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price for the company. Finally, Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $74.00 to $73.00 in a research report on Friday, May 5th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company’s stock. Stericycle currently has an average rating of “Hold” and a consensus price target of $81.15.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.